FDA OKs expansion of DMD stem cell trial, allows 30 more boys

The U.S. Food and Drug Administration (FDA) has allowed the enrollment of up to 30 additional boys with Duchenne muscular dystrophy (DMD) in a clinical study testing an experimental stem cell therapy. The Phase 2 trial (NCT06579352) testing the treatment from Signature Biologics has enrolled five boys, ages 5 to 10, at two sites in […] The post FDA OKs expansion of DMD stem cell trial, allows 30…